Zhou W - Search Results

1

Lung Cancer-Specific Mortality Risk and Public Health Insurance: A Prospective Cohort Study in Chongqing, Southwest China.

Wang Y, Lei H, Li X, Zhou W, Wang G, Sun A, Wang Y, Wu Y, Peng B. Wang Y, et al. Among authors: zhou w. Front Public Health. 2022 Apr 29;10:842844. doi: 10.3389/fpubh.2022.842844. eCollection 2022. Front Public Health. 2022. PMID: 35570974 Free PMC article.

2

Higher mortality in lung cancer patients with COVID-19? A systematic review and meta-analysis.

Lei H, Yang Y, Zhou W, Zhang M, Shen Y, Tao D, Wang L, Lei Q, Wang Y, Wu Y. Lei H, et al. Among authors: zhou w. Lung Cancer. 2021 Jul;157:60-65. doi: 10.1016/j.lungcan.2021.05.002. Epub 2021 May 5. Lung Cancer. 2021. PMID: 33985850 Free PMC article.

3

Development and Validation of a Risk Prediction Model for Venous Thromboembolism in Lung Cancer Patients Using Machine Learning.

Lei H, Zhang M, Wu Z, Liu C, Li X, Zhou W, Long B, Ma J, Zhang H, Wang Y, Wang G, Gong M, Hong N, Liu H, Wu Y. Lei H, et al. Among authors: zhou w. Front Cardiovasc Med. 2022 Mar 7;9:845210. doi: 10.3389/fcvm.2022.845210. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35321110 Free PMC article.

4

Plasma microRNA expression signature involving miR-548q, miR-630 and miR-940 as biomarkers for nasopharyngeal carcinoma detection.

Zhuo X, Zhou W, Li D, Chang A, Wang Y, Wu Y, Zhou Q. Zhuo X, et al. Among authors: zhou w, zhou q. Cancer Biomark. 2018;23(4):579-587. doi: 10.3233/CBM-181852. Cancer Biomark. 2018. PMID: 30475754

5

Comparison of Radiation Pneumonitis in Lung Cancer Patients Treated with HT versus IMRT and Circulating Lymphocyte Subsets as Predicting Risk Factors.

Zhang X, Yang D, Jiang Y, Huang L, Wang C, Tao D, Liu X, Lei Y, Wu Y, Zhou W. Zhang X, et al. Among authors: zhou w. J Inflamm Res. 2021 Aug 28;14:4205-4215. doi: 10.2147/JIR.S328955. eCollection 2021. J Inflamm Res. 2021. PMID: 34483676 Free PMC article.

6

Protective Effect of Blood Cora Polysaccharides on H9c2 Rat Heart Cells Injury Induced by Oxidative Stress by Activating Nrf2/HO-1 Signal Pathway.

Jiang Y, Zhou W, Zhang X, Wang Y, Yang D, Li S. Jiang Y, et al. Among authors: zhou w. Front Nutr. 2021 Mar 2;8:632161. doi: 10.3389/fnut.2021.632161. eCollection 2021. Front Nutr. 2021. PMID: 33738296 Free PMC article.

7

Activation of the phosphorylation of ATM contributes to radioresistance of glioma stem cells.

Zhou W, Sun M, Li GH, Wu YZ, Wang Y, Jin F, Zhang YY, Yang L, Wang DL. Zhou W, et al. Oncol Rep. 2013 Oct;30(4):1793-801. doi: 10.3892/or.2013.2614. Epub 2013 Jul 11. Oncol Rep. 2013. PMID: 23846672

8

Silencing of RegIV by shRNA causes the loss of stemness properties of cancer stem cells in MKN45 gastric cancer cells.

Zhou W, Sun M, Wang DL, Wang Y, Jin F, Zhang YY, Yang L, Wu XL, Wu YZ. Zhou W, et al. Oncol Rep. 2013 Dec;30(6):2685-90. doi: 10.3892/or.2013.2745. Epub 2013 Sep 20. Oncol Rep. 2013. PMID: 24064664

9

Screening of key miRNAs and evaluation of their diagnostic and prognostic values in nasopharyngeal carcinoma.

Zhuo X, Zhou W, Ye H, Li D, Chang A, Wu Y, Zhou Q. Zhuo X, et al. Among authors: zhou w, zhou q. Oncol Lett. 2019 Jun;17(6):5803-5810. doi: 10.3892/ol.2019.10231. Epub 2019 Apr 9. Oncol Lett. 2019. PMID: 31186807 Free PMC article.

10

The Role of Additional Chemotherapy in Combination with Concurrent Chemoradiotherapy for Locally Advanced Inoperable Non-Small Cell Lung Cancer, a Systematic Review and Meta-Analysis of 12 Randomized Trials.

Ying M, Liu J, Zhou W, Weng K, Long B, Wang Y. Ying M, et al. Among authors: zhou w. Cancer Invest. 2019;37(8):376-386. doi: 10.1080/07357907.2019.1656730. Epub 2019 Sep 2. Cancer Invest. 2019. PMID: 31474153

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23,151 results

Search Page

Filters